Ameriprise Financial Inc Xencor Inc Transaction History

Ameriprise Financial Inc

  • $381 Billion
  • Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Xencor Inc stock. As of the latest transaction made, Ameriprise Financial Inc holds 169,706 shares of XNCR stock, worth $4.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
169,706
Previous 192,041 11.63%
Holding current value
$4.1 Million
Previous $3.64 Million 6.13%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$15.7 - $21.65 $350,659 - $483,552
-22,335 Reduced 11.63%
169,706 $3.41 Million
Q2 2024

Aug 14, 2024
SELL
$18.21 - $24.5 $688,975 - $926,957
-37,835 Reduced 16.46%
192,041 $3.64 Million
Q1 2024

May 15, 2024
SELL
$18.65 - $26.52 $456,440 - $649,050
-24,474 Reduced 9.62%
229,876 $5.09 Million
Q4 2023

Feb 14, 2024
SELL
$16.53 - $21.42 $1.6 Million - $2.08 Million
-96,916 Reduced 27.59%
254,350 $5.4 Million
Q3 2023

Nov 14, 2023
SELL
$20.08 - $25.39 $558,123 - $705,715
-27,795 Reduced 7.33%
351,266 $7.08 Million
Q2 2023

Aug 14, 2023
SELL
$24.77 - $29.9 $200,215 - $241,681
-8,083 Reduced 2.09%
379,061 $9.47 Million
Q1 2023

May 15, 2023
SELL
$25.95 - $36.95 $184,037 - $262,049
-7,092 Reduced 1.8%
387,144 $10.8 Million
Q4 2022

Feb 14, 2023
BUY
$24.79 - $30.86 $490,296 - $610,349
19,778 Added 5.28%
394,236 $10.3 Million
Q3 2022

Nov 14, 2022
BUY
$24.62 - $32.44 $2.24 Million - $2.95 Million
91,021 Added 32.11%
374,458 $9.73 Million
Q2 2022

Aug 15, 2022
BUY
$19.74 - $29.01 $182,910 - $268,806
9,266 Added 3.38%
283,437 $7.76 Million
Q1 2022

May 16, 2022
BUY
$26.68 - $41.63 $230,061 - $358,975
8,623 Added 3.25%
274,171 $7.32 Million
Q4 2021

Feb 14, 2022
BUY
$33.67 - $43.44 $107,171 - $138,269
3,183 Added 1.21%
265,548 $10.7 Million
Q3 2021

Nov 15, 2021
SELL
$30.65 - $35.68 $215,285 - $250,616
-7,024 Reduced 2.61%
262,365 $8.57 Million
Q2 2021

Aug 16, 2021
SELL
$34.33 - $44.68 $579,112 - $753,706
-16,869 Reduced 5.89%
269,389 $9.29 Million
Q1 2021

May 17, 2021
SELL
$40.81 - $53.88 $178,951 - $236,263
-4,385 Reduced 1.51%
286,258 $12.3 Million
Q4 2020

Feb 12, 2021
SELL
$36.63 - $47.63 $1.02 Million - $1.33 Million
-27,958 Reduced 8.78%
290,643 $12.7 Million
Q3 2020

Nov 16, 2020
BUY
$30.09 - $43.02 $733,714 - $1.05 Million
24,384 Added 8.29%
318,601 $12.4 Million
Q2 2020

Aug 14, 2020
BUY
$27.76 - $33.42 $1.04 Million - $1.25 Million
37,352 Added 14.54%
294,217 $9.53 Million
Q1 2020

May 15, 2020
BUY
$20.69 - $37.79 $6,724 - $12,281
325 Added 0.13%
256,865 $7.67 Million
Q4 2019

Feb 14, 2020
SELL
$32.75 - $41.43 $253,648 - $320,875
-7,745 Reduced 2.93%
256,540 $8.82 Million
Q3 2019

Nov 14, 2019
BUY
$33.73 - $46.27 $8.91 Million - $12.2 Million
264,285 New
264,285 $8.92 Million

Others Institutions Holding XNCR

# of Institutions
215
Shares Held
71.5M
Call Options Held
2.5K
Put Options Held
7.9K
View Full List

About Xencor Inc

XNCR Quotes by TradingView
  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.44B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email